Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune su...

by Hong Chen, Padmanee Sharma, James P Allison, Sumit K Subudhi, Sonali Jindal, Sreyashi Basu, Bilal A Siddiqui, Paul G Corn, Ana M Aparicio, Shalini S Yadav, Rebecca S S Tidwell, Ashwin Varma, Christopher J Logothetis
Published 2021-10-01

Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments

by Paul V. Viscuse, Rebecca S. Slack-Tidwell, Miao Zhang, Prih Rohra, Keyi Zhu, F. Anthony San Lucas, Eric Konnick, Patrick G. Pilie, Bilal Siddiqui, Christopher J. Logothetis, Paul Corn, Sumit K. Subudhi, Colin C. Pritchard, Rama Soundararajan, Ana Aparicio
Published 2023-12-01

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

by Charles G Drake, Padmanee Sharma, Sumit K Subudhi, Patricia Troncoso, Sonali Jindal, Sreyashi Basu, Bilal A Siddiqui, Paul G Corn, Shalini S Yadav, Rebecca S S Tidwell, Christopher J Logothetis, Fei Duan, Brian F Chapin, Ai-Di Gu, Alexsandra B Espejo, Michelle Kinder, Curtis A Pettaway, John F Ward, Roland Knoblauch, Natalie Hutnick, Marco Gottardis
Published 2023-03-01

Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components

by Rama Soundararajan, Paul Viscuse, Patrick Pilie, Jingjing Liu, Souzana Logotheti, Caddie Laberiano Fernández, Daniele Lorenzini, Anh Hoang, Wei Lu, Luisa Maren Solis Soto, Ignacio I. Wistuba, Mingchu Xu, Xingzhi Song, Peter D. A. Shepherd, Nora M. Navone, Rebecca S. S. Tidwell, Guillermina Lozano, Christopher Logothetis, Jianhua Zhang, James P. Long, Marcos R. Estecio, Vasiliki Tzelepi, Ana M. Aparicio
Published 2022-06-01